Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
8 participants
INTERVENTIONAL
2018-07-01
2020-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus
NCT07080983
Influence of Corneal Biomechanical Properties on Myopia Control
NCT05090592
Iontophoretic Transepithelial Corneal Cross-linking in Pediatric Patients
NCT03661164
Hyperopic LASIK With Crosslinking Versus Standard LASIK
NCT03224013
Corneal Topography Asymmetry Indices Changes After Corneal Refractive Surgery
NCT04589091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
penetrating keratoplasty
A prospective non-comparative non-randomized clinical study which was conducted on 12 eyes of 8 patients 4 males and 4 females who underwent PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction
PKP
1. The horizontal axis was marked with a pointed marker at the slit lamp immediately before surgery.
2. TICL loading into the STAAR injector cartridge
3. Temporal clear corneal 3 mm incision \& 2-side ports then viscoelastic injection into the AC
4. Implantation of the TICL using the injector, then rotation according to the implantation diagram guided with Mendez protractor, and lastly placement of the haptics under the iris.
5. Pupil constriction with A.Ch.
6. Washing the viscoelastic \&Wound hydration.
7. Topical antibiotic steroids (Vigamox and Tobradex) 4 times /day for 3weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PKP
1. The horizontal axis was marked with a pointed marker at the slit lamp immediately before surgery.
2. TICL loading into the STAAR injector cartridge
3. Temporal clear corneal 3 mm incision \& 2-side ports then viscoelastic injection into the AC
4. Implantation of the TICL using the injector, then rotation according to the implantation diagram guided with Mendez protractor, and lastly placement of the haptics under the iris.
5. Pupil constriction with A.Ch.
6. Washing the viscoelastic \&Wound hydration.
7. Topical antibiotic steroids (Vigamox and Tobradex) 4 times /day for 3weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ehab Mossallam, PhD
Role: PRINCIPAL_INVESTIGATOR
Alexandria Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria Faculty of Medicine
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0304624
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.